A G Agusti

Summary

Country: Spain

Publications

  1. ncbi Exhaled nitric oxide in patients with sleep apnea
    A G Agusti
    Servei de Pneumologia, Hospital Universitari Son Dureta, Palma, Mallorca, Spain
    Sleep 22:231-5. 1999
  2. ncbi Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial
    F Barbe
    Servei de Pneumologia, Hospital Universitari Son Dureta, Andrea Doria, 55, 07014 Palma de Mallorca, Spain
    Ann Intern Med 134:1015-23. 2001
  3. ncbi Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms
    A Barcelo
    Unitat d Investigació REUNI, Hospital Universitari Son Dureta, Palma de Mallorca, Spain
    Eur Respir J 17:728-32. 2001

Collaborators

Detail Information

Publications3

  1. ncbi Exhaled nitric oxide in patients with sleep apnea
    A G Agusti
    Servei de Pneumologia, Hospital Universitari Son Dureta, Palma, Mallorca, Spain
    Sleep 22:231-5. 1999
    ..These results show that [NOexh] is not abnormal in patients with OSAS, and that it does not relate to the presence of cardiovascular disease or to any of various common indices of disease severity...
  2. ncbi Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial
    F Barbe
    Servei de Pneumologia, Hospital Universitari Son Dureta, Andrea Doria, 55, 07014 Palma de Mallorca, Spain
    Ann Intern Med 134:1015-23. 2001
    ..However, the effect of CPAP in persons with a pathologic apnea-hypopnea index without daytime sleepiness is unclear...
  3. ncbi Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms
    A Barcelo
    Unitat d Investigació REUNI, Hospital Universitari Son Dureta, Palma de Mallorca, Spain
    Eur Respir J 17:728-32. 2001
    ..356). These results indicate that ACE plasma activity is increased in untreated OSAS patients. This increased activity may contribute to the pathogenesis of the cardiovascular disease in these patients...